Baker Bros. Advisors LP Tyra Biosciences, Inc. Transaction History
Baker Bros. Advisors LP
- $9.34 Billion
- Q3 2024
A detailed history of Baker Bros. Advisors LP transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 10,607 shares of TYRA stock, worth $159,741. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,607
Previous 10,607
-0.0%
Holding current value
$159,741
Previous $169,000
47.34%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
98Shares Held
43.5MCall Options Held
353KPut Options Held
1.1K-
Ra Capital Management, L.P. Boston, MA10.4MShares$157 Million3.41% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$97.1 Million8.05% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$70.2 Million3.48% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$66.4 Million97.89% of portfolio
-
Nextech Invest Ag4.06MShares$61.1 Million15.55% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $632M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...